Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Assets Average (2020 - 2025)

Historic Assets Average for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $755.5 million.

  • Mirum Pharmaceuticals' Assets Average rose 1372.02% to $755.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $755.5 million, marking a year-over-year increase of 1372.02%. This contributed to the annual value of $658.7 million for FY2024, which is 3179.98% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Assets Average stood at $755.5 million, which was up 1372.02% from $708.0 million recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Assets Average high stood at $755.5 million for Q3 2025, and its period low was $231.6 million during Q1 2021.
  • Its 5-year average for Assets Average is $470.9 million, with a median of $388.6 million in 2023.
  • Over the last 5 years, Mirum Pharmaceuticals' Assets Average had its largest YoY gain of 8917.76% in 2024, and its largest YoY loss of 319.01% in 2024.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Assets Average stood at $264.9 million in 2021, then skyrocketed by 35.38% to $358.6 million in 2022, then skyrocketed by 80.87% to $648.6 million in 2023, then grew by 3.19% to $669.3 million in 2024, then grew by 12.87% to $755.5 million in 2025.
  • Its Assets Average was $755.5 million in Q3 2025, compared to $708.0 million in Q2 2025 and $680.5 million in Q1 2025.